Innovating translational research.
Improving quality of life after cancer.

The biomedical field has made tremendous strides in turning many cancers into survivable diseases.  However, treatment-related effects can:

• Impact a patient’s ability to adhere to and realize the full benefit of existing therapies;
• Make daily tasks challenging and reduce overall quality of life;
• Lead to significantly higher incidence of severe chronic illness in survivors;
• Include cardiac dysfunction or failure, pulmonary problems, neurological issues, liver toxicity, and endocrine disorders among others.

THRIVE fills a critical gap in funding for foundational research in support of future protective therapies, mitigation strategies and a next generation of therapy and therapy-support that will enhance the ability for cancer patients and survivors to THRIVE.

JOIN US IN MAKING A DIFFERENCE!